These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11122853)

  • 1. Recent developments in Barrett's esophagus.
    Garewal HS
    Curr Oncol Rep; 2000 May; 2(3):271-6. PubMed ID: 11122853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus].
    Osminin SV; Vetshev FP; Rudenko VV; Zaletaev DV; Khorobrykh TV; Nemtsova MV
    Klin Lab Diagn; 2016 Oct; 61(10):681-5. PubMed ID: 30615323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
    Zhang W; Wang DH
    Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential.
    Clark GW; Ireland AP; Peters JH; Chandrasoma P; DeMeester TR; Bremner CG
    J Gastrointest Surg; 1997; 1(2):113-22. PubMed ID: 9834337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
    Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ
    Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of adenocarcinoma in Barrett's esophagus: p53 and Ki67 expression and histopathologic background.
    Szachnowicz S; Cecconello I; Iriya K; Marson AG; Takeda FR; Gama-Rodrigues JJ
    Clinics (Sao Paulo); 2005 Apr; 60(2):103-12. PubMed ID: 15880245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
    Sharma P
    Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers.
    Peters FT; Ganesh S; Kuipers EJ; de Jager-Krikken A; Karrenbeld A; Harms G; Sluiter WJ; Koudstaal J; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
    Dig Dis Sci; 1998 Jul; 43(7):1501-6. PubMed ID: 9690386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Barrett's esophagus free of dysplasia.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance of patients with Barrett's esophagus].
    Endlicher E; Knüchel R; Messmann H
    Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of esophageal cancer from reflux esophagitis].
    Kawano T; Nakajima Y; Kawada K
    Nihon Rinsho; 2016 Aug; 74(8):1393-1400. PubMed ID: 30562449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histochemical diagnosis of short segment Barrett's esophagus].
    Fujiyama Y; Ishizuka I; Koyama S
    Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.